A couple of weeks ago, the Wall Street Journal ran an editorial that complained that FDA Commissioner Makary had touted dodgy evidence about the potential harms of talcum powder in food and medications,[1] and called an improper public meeting to discuss his concerns. The editorial noted the procedural irregularity of convening a meeting to review evidence of the supposed harms of talc in food and drugs, without proper notice and public comment.[2] The panel met just four days after the FDA...
